-DOCSTART- -X- O
BACKGROUND -X- _ O
: -X- _ O
IgY -X- _ O
antibodies -X- _ O
are -X- _ O
serum -X- _ O
immunoglobulin -X- _ O
in -X- _ O
birds -X- _ O
, -X- _ O
reptiles -X- _ O
and -X- _ O
amphibians -X- _ O
, -X- _ O
and -X- _ O
are -X- _ O
transferred -X- _ O
from -X- _ O
serum -X- _ O
to -X- _ O
egg -X- _ O
yolk -X- _ O
to -X- _ O
confer -X- _ O
passive -X- _ O
immunity -X- _ O
to -X- _ O
their -X- _ O
embryos -X- _ O
and -X- _ O
offspring. -X- _ O
Currently -X- _ O
, -X- _ O
the -X- _ O
oral -X- _ O
passive -X- _ O
immunization -X- _ O
using -X- _ O
chicken -X- _ B-Intervention
IgY -X- _ I-Intervention
has -X- _ O
been -X- _ O
focused -X- _ O
as -X- _ O
an -X- _ O
alternative -X- _ O
to -X- _ O
antibiotics -X- _ O
for -X- _ O
the -X- _ O
treatment -X- _ O
and -X- _ O
control -X- _ O
of -X- _ O
diarrhea -X- _ B-Patient
in -X- _ I-Patient
animals -X- _ I-Patient
and -X- _ O
humans. -X- _ O
This -X- _ O
systematic -X- _ O
review -X- _ O
was -X- _ O
focused -X- _ O
to -X- _ O
determine -X- _ O
the -X- _ O
effect -X- _ O
of -X- _ O
IgY -X- _ O
in -X- _ O
controlling -X- _ O
and -X- _ O
preventing -X- _ O
diarrhea -X- _ B-Patient
in -X- _ I-Patient
domesticated -X- _ I-Patient
animals -X- _ I-Patient
including -X- _ I-Patient
Piglets -X- _ I-Patient
, -X- _ I-Patient
Mice -X- _ I-Patient
, -X- _ I-Patient
Poultry -X- _ I-Patient
and -X- _ I-Patient
Calves. -X- _ I-Patient
METHODS -X- _ O
AND -X- _ O
RESULTS -X- _ O
: -X- _ O
Previous -X- _ O
research -X- _ O
reports -X- _ O
focused -X- _ O
on -X- _ O
treatment -X- _ O
effect -X- _ O
of -X- _ O
Chicken -X- _ B-Intervention
IgY -X- _ I-Intervention
against -X- _ O
diarrhea -X- _ O
were -X- _ O
retrieved -X- _ O
from -X- _ O
different -X- _ O
electronic -X- _ O
data -X- _ O
bases -X- _ O
( -X- _ O
MEDLINE -X- _ O
, -X- _ O
EMBASE -X- _ O
, -X- _ O
SPRINGER-LINK -X- _ O
, -X- _ O
WILEY -X- _ O
, -X- _ O
AGRICOLA -X- _ O
, -X- _ O
MEDWELL -X- _ O
Journals -X- _ O
, -X- _ O
Scientific -X- _ O
Publish -X- _ O
, -X- _ O
Chinese -X- _ O
articles -X- _ O
from -X- _ O
Core -X- _ O
periodicals -X- _ O
in -X- _ O
2012 -X- _ O
) -X- _ O
. -X- _ O
A -X- _ O
total -X- _ O
of -X- _ O
61 -X- _ O
studies -X- _ O
in -X- _ O
4 -X- _ O
different -X- _ O
animal -X- _ O
classes -X- _ O
met -X- _ O
the -X- _ O
inclusion -X- _ O
criteria. -X- _ O
Data -X- _ O
on -X- _ O
study -X- _ O
characteristics -X- _ O
and -X- _ O
outcome -X- _ O
measures -X- _ O
were -X- _ O
extracted. -X- _ O
The -X- _ B-Outcome
pooled -X- _ I-Outcome
relative -X- _ I-Outcome
risk -X- _ I-Outcome
( -X- _ I-Outcome
RR -X- _ I-Outcome
) -X- _ I-Outcome
of -X- _ I-Outcome
49 -X- _ I-Outcome
studies -X- _ I-Outcome
of -X- _ I-Outcome
different -X- _ I-Outcome
animals -X- _ I-Outcome
[ -X- _ I-Outcome
Piglets -X- _ I-Outcome
– -X- _ I-Outcome
22 -X- _ I-Outcome
; -X- _ I-Outcome
Mice -X- _ I-Outcome
– -X- _ I-Outcome
14 -X- _ I-Outcome
; -X- _ I-Outcome
Poultry -X- _ I-Outcome
– -X- _ I-Outcome
7 -X- _ I-Outcome
and -X- _ I-Outcome
Calves -X- _ I-Outcome
– -X- _ I-Outcome
6 -X- _ I-Outcome
] -X- _ I-Outcome
in -X- _ I-Outcome
meta-analyses -X- _ I-Outcome
revealed -X- _ I-Outcome
that -X- _ I-Outcome
, -X- _ I-Outcome
IgY -X- _ I-Outcome
significantly -X- _ I-Outcome
reduced -X- _ I-Outcome
the -X- _ I-Outcome
risk -X- _ I-Outcome
of -X- _ I-Outcome
diarrhea -X- _ I-Outcome
in -X- _ I-Outcome
treatment -X- _ I-Outcome
group -X- _ I-Outcome
when -X- _ I-Outcome
compare -X- _ I-Outcome
to -X- _ I-Outcome
the -X- _ I-Outcome
placebo. -X- _ I-Outcome
However -X- _ I-Outcome
, -X- _ I-Outcome
the -X- _ I-Outcome
95 -X- _ I-Outcome
% -X- _ I-Outcome
confidence -X- _ I-Outcome
intervals -X- _ I-Outcome
of -X- _ I-Outcome
the -X- _ I-Outcome
majority -X- _ I-Outcome
of -X- _ I-Outcome
studies -X- _ I-Outcome
in -X- _ I-Outcome
animal -X- _ I-Outcome
class -X- _ I-Outcome
piglets -X- _ I-Outcome
and -X- _ I-Outcome
calves -X- _ I-Outcome
embrace -X- _ I-Outcome
RR -X- _ I-Outcome
of -X- _ I-Outcome
one. -X- _ I-Outcome
The -X- _ I-Outcome
same -X- _ I-Outcome
results -X- _ I-Outcome
were -X- _ I-Outcome
obtained -X- _ I-Outcome
in -X- _ I-Outcome
sub -X- _ I-Outcome
group -X- _ I-Outcome
analyses -X- _ I-Outcome
( -X- _ I-Outcome
treatment -X- _ I-Outcome
regiment -X- _ I-Outcome
– -X- _ I-Outcome
prophylactic -X- _ I-Outcome
or -X- _ I-Outcome
therapeutic -X- _ I-Outcome
; -X- _ I-Outcome
pathogen -X- _ I-Outcome
type -X- _ I-Outcome
– -X- _ I-Outcome
bacterial -X- _ I-Outcome
or -X- _ I-Outcome
viral -X- _ I-Outcome
) -X- _ I-Outcome
. -X- _ I-Outcome
Perhaps -X- _ I-Outcome
, -X- _ I-Outcome
this -X- _ I-Outcome
inconsistency -X- _ I-Outcome
in -X- _ I-Outcome
the -X- _ I-Outcome
effect -X- _ I-Outcome
of -X- _ I-Outcome
IgY -X- _ I-Outcome
at -X- _ I-Outcome
the -X- _ I-Outcome
individual -X- _ I-Outcome
study -X- _ I-Outcome
level -X- _ I-Outcome
and -X- _ I-Outcome
overall -X- _ I-Outcome
effect -X- _ I-Outcome
measures -X- _ I-Outcome
could -X- _ I-Outcome
be -X- _ I-Outcome
influenced -X- _ I-Outcome
by -X- _ I-Outcome
the -X- _ I-Outcome
methodological -X- _ I-Outcome
heterogeneity. -X- _ I-Outcome
CONCLUSION -X- _ O
: -X- _ O
The -X- _ O
present -X- _ O
systematic -X- _ O
review -X- _ O
( -X- _ O
SR -X- _ O
) -X- _ O
and -X- _ O
meta-analysis -X- _ O
demonstrated -X- _ O
the -X- _ O
beneficial -X- _ O
effect -X- _ O
of -X- _ O
IgY. -X- _ O
This -X- _ O
supports -X- _ O
the -X- _ O
opinion -X- _ O
that -X- _ O
IgY -X- _ O
is -X- _ O
useful -X- _ O
for -X- _ O
prophylaxis -X- _ O
and -X- _ O
treatment. -X- _ O
However -X- _ O
, -X- _ O
more -X- _ O
intensive -X- _ O
studies -X- _ O
using -X- _ O
the -X- _ O
gold -X- _ O
standard -X- _ O
animal -X- _ O
experiments -X- _ O
with -X- _ O
the -X- _ O
focus -X- _ O
to -X- _ O
use -X- _ O
IgY -X- _ O
alone -X- _ O
or -X- _ O
in -X- _ O
combination -X- _ O
with -X- _ O
other -X- _ O
alternative -X- _ O
strategies -X- _ O
are -X- _ O
indispensable -X- _ O
. -X- _ O

